Cargando…

Encouraging Early Outcomes of Treatment With Arsenic Trioxide Combined With Chemotherapy for Alveolar Rhabdomyosarcoma in Children: 4 Case Reports

BACKGROUND: Alveolar rhabdomyosarcoma (ARMS) is a subtype of rhabdomyosarcoma characterized by its aggressive behavior and poor prognosis, highlighting the need for novel treatment options. Arsenic trioxide (ATO) has been shown to specifically inhibit tumor growth and the metastasis of ARMS in vitro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Peng, Xiaomin, Xiong, Xilin, Li, Yang, Feng, Chuchu, Liu, Hongyan, Wu, Pingping, Li, Chunmou, Weng, Wenjun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8586416/ https://www.ncbi.nlm.nih.gov/pubmed/34778066 http://dx.doi.org/10.3389/fonc.2021.751623

Ejemplares similares

Improved Outcomes with Induction Chemotherapy Combined with Arsenic Trioxide in Stage 4 Neuroblastoma: A Case Series
por: Li, Yang, et al.
Publicado: (2021)

Excellent Early Outcomes of Combined Chemotherapy With Arsenic Trioxide for Stage 4/M Neuroblastoma in Children: A Multicenter Nonrandomized Controlled Trial
por: Li, Chunmou, et al.
Publicado: (2021)

Serum brain-derived neurotrophic factor (BDNF) as predictors of childhood neuroblastoma relapse
por: Xiong, Xilin, et al.
Publicado: (2023)

Alveolar rhabdomyosarcoma of epididymis: A case report
por: Liang, Xiangyi, et al.
Publicado: (2022)

Immune Microenvironment in Langerhans Cell Histiocytosis: Potential Prognostic Indicators
por: Feng, Chuchu, et al.
Publicado: (2021)

Parthenolide and arsenic trioxide co-trigger autophagy-accompanied apoptosis in hepatocellular carcinoma cells
por: Yi, Juan, et al.
Publicado: (2022)

Combined application of arsenic trioxide and lithium chloride augments viability reduction and apoptosis induction in human rhabdomyosarcoma cell lines
por: Schleicher, Sabine B., et al.
Publicado: (2017)

The genomic landscape of sensitivity to arsenic trioxide uncovered by genome-wide CRISPR-Cas9 screening
por: Chen, Jun-Zhu, et al.
Publicado: (2023)

Arsenic Trioxide Promotes Tumor Progression by Inducing the Formation of PGCCs and Embryonic Hemoglobin in Colon Cancer Cells
por: Li, Zugui, et al.
Publicado: (2021)

Oral arsenic trioxide for treating acute promyelocytic leukaemia: Implications for its worldwide epidemiology and beyond
por: Kumana, Cyrus R., et al.
Publicado: (2022)

UNC13B Promote Arsenic Trioxide Resistance in Chronic Lymphoid Leukemia Through Mitochondria Quality Control
por: Wang, Xiao-Bo, et al.
Publicado: (2022)

Efficacy and Tolerability of First Line Arsenic Trioxide in Combination With All-Trans Retinoic Acid in Patients With Acute Promyelocytic Leukemia: Real Life Experience
por: Autore, Francesco, et al.
Publicado: (2021)

Resurrection of Oral Arsenic Trioxide for Treating Acute Promyelocytic Leukaemia: A Historical Account From Bedside to Bench to Bedside
por: Kumana, Cyrus R., et al.
Publicado: (2020)

Alveolar rhabdomyosarcoma of maxilla
por: Ananthaneni, Anuradha, et al.
Publicado: (2016)

Arsenic trioxide induces cell cycle arrest and affects Trk receptor expression in human neuroblastoma SK-N-SH cells
por: Xiong, Xilin, et al.
Publicado: (2018)

Arsenic Trioxide Therapy During Pregnancy: ATO and Its Metabolites in Maternal Blood and Amniotic Fluid of Acute Promyelocytic Leukemia Patients
por: Guo, Meihua, et al.
Publicado: (2022)

In silico mechanisms of arsenic trioxide-induced cardiotoxicity
por: Li, Yacong, et al.
Publicado: (2022)

Inhibition of FEN1 Increases Arsenic Trioxide-Induced ROS Accumulation and Cell Death: Novel Therapeutic Potential for Triple Negative Breast Cancer
por: Xin, Xing, et al.
Publicado: (2020)

Lenalidomide in Combination with Arsenic Trioxide: an Effective Therapy for Primary Effusion Lymphoma
por: Moodad, Sara, et al.
Publicado: (2020)

Alveolar rhabdomyosarcoma with massive disseminated intravascular coagulopathy treated with systemic chemotherapy
por: Yoon, Byung Gyu, et al.
Publicado: (2015)

A bioengineering method for modeling alveolar Rhabdomyosarcoma and assessing chemotherapy responses
por: Stefanek, Evan, et al.
Publicado: (2021)

Human Rhabdomyosarcoma Cell Lines for Rhabdomyosarcoma Research: Utility and Pitfalls
por: Hinson, Ashley R. P., et al.
Publicado: (2013)

Evidences of Protective Potentials of Microdoses of Ultra-High Diluted Arsenic Trioxide in Mice Receiving Repeated Injections of Arsenic Trioxide
por: Banerjee, Pathikrit, et al.
Publicado: (2011)

The Case for Primary Salivary Rhabdomyosarcoma
por: Geltzeiler, Mathew, et al.
Publicado: (2015)

A case of complete response to chemotherapy followed by cystectomy for adult-onset rhabdomyosarcoma of the bladder
por: Ito, Ayato, et al.
Publicado: (2022)

Effects of arsenic trioxide on the expression of ezrin in hepatocellular carcinoma
por: Lu, Wei, et al.
Publicado: (2017)

A case report of primary para-testicular spindle cell rhabdomyosarcoma
por: Su, Peng, et al.
Publicado: (2023)

Arsenic trioxide as an inducer of immunogenic cell death
por: Kepp, Oliver, et al.
Publicado: (2023)

Immunological consequences of arsenic trioxide-induced necrosis
por: Gavali, Shubhangi, et al.
Publicado: (2023)

Effect of arsenic trioxide on cervical cancer and its mechanisms
por: Zhang, Liping, et al.
Publicado: (2020)

Retracted: Evidences of Protective Potentials of Microdoses of Ultra-High Diluted Arsenic Trioxide in Mice Receiving Repeated Injections of Arsenic Trioxide
por: Medicine, Evidence-Based Complementary and Alternative
Publicado: (2021)

Combinatorial Low Dose Arsenic Trioxide and Cisplatin Exacerbates Autophagy via AMPK/STAT3 Signaling on Targeting Head and Neck Cancer Initiating Cells
por: Hu, Wei-Chun, et al.
Publicado: (2020)

Personalized therapy: CNS HGNET-BCOR responsiveness to arsenic trioxide combined with radiotherapy
por: Paret, Claudia, et al.
Publicado: (2017)

Phase I/II trial of local interstitial chemotherapy with arsenic trioxide in patients with newly diagnosed glioma
por: Han, Dayong, et al.
Publicado: (2022)

The antitumor effect of arsenic trioxide on hepatocellular carcinoma is enhanced by andrographolide
por: Duan, Xuhua, et al.
Publicado: (2017)

Rhabdomyosarcoma of the kidney: A case report
por: Shuyu, Li, et al.
Publicado: (2022)

Arsenic trioxide improves hematopoiesis in refractory severe aplastic anemia
por: Li, Ning, et al.
Publicado: (2012)

Arsenic trioxide targets Hsp60, triggering degradation of p53 and survivin
por: Hu, Xuqiao, et al.
Publicado: (2021)

Evaluation of the target genes of arsenic trioxide in pancreatic cancer by bioinformatics analysis
por: Zhou, Cong-Ya, et al.
Publicado: (2019)

Local delivery of arsenic trioxide nanoparticles for hepatocellular carcinoma treatment
por: Hu, Jian, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_7nckqj6ofmlku31fht2g99rdd2